LYMPRO launched AMBS pps in July, it will repeat the launch
LYMPRO launched AMBS pps in July, it will repeat the launch in January I believe. One fact is certain, LYMPRO has the attention of everyone:
1) Investors....we saw the interest in July, and the anticipation exploded the pps to a new high .19
2) Bashers, who understand the magnitude and significance of LYMPRO for the BP clinical trials, and then the general public at large
so they continue to bash the stock trying desperately to drive down the pps to buy more. This group understands well that
the commercial launch of LYMPRO to the RUO BP market on Dec. 22 2014 which will initiate revenues this quarter and beyond
3)BP and perhaps hedge funds because Amarantus expects to announce the full results of its in-depth analysis of the full mild-to-severe AD cohort of 140 subjects (initial 72 patients + 68 patient extension) by year-end 2014, and make a final determination on which assay conditions (Version 1 vs. Version 2) it will use to support its product launch. CLIA launch will follow with a potential 3 Billion Mkt...
Yes, LYMPRO will launch AMBS just like it did before, but this time will have the supporting data. I do believe along with everyone else, including the "serial bashers" that LYMPRO will launch AMBS pps in 2015. Don't be deceived by the constant bashing of a few who have a clear agenda. Buckle up and prepared for an epic ride in 2015 and beyond I believe. Do your own DD and tune out the white noise!
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Top 5 Most Recently Viewed Articles
Arch Capital Group Reports Third Quarter Financial Success Arch Capital Group Ltd. (NASDAQ: ACGL) recently announced strong financial results for the third quarter. This report signifies a remarkable achievement for the company as it reflects the overall financial health and operational efficiency across its diverse business segments. Strong Financial Performance The net...
Continue Reading
Welcome to the New Era of Cryptocurrency Trading with BexBack The cryptocurrency market is known for its unpredictability, and with Bitcoin's price teetering around $100,000, many traders find themselves navigating a landscape filled with uncertainty. In such a turbulent environment, seasoned investors are increasingly turning to futures trading with 100x leverage to...
Continue Reading
MasHash Launches Innovative Cloud-Based Mining Platform MasHash, a prominent provider of cloud-based cryptocurrency mining solutions, has unveiled its latest and improved mining platform. This new offering aims to revolutionize how users participate in crypto mining and enhance their profitability. The Growing Significance of Crypto Mining in 2024 As we enter 2024, the...
Continue Reading
Investor Event Scheduled for December Syndax Pharmaceuticals (Nasdaq: SNDX), a pioneering biopharmaceutical company renowned for its cutting-edge cancer treatments, has announced an upcoming investor event. This event will allow attendees to engage directly with the Syndax team and learn more about the groundbreaking research being conducted in the field of oncology....
Continue Reading
Introducing Seguritech's Innovative Smartwatch Seguritech has taken a bold step in personal safety with the introduction of its Early Warning Smartwatch. This remarkable device connects users seamlessly to a network of Command and Control Centers, ensuring immediate access to emergency responders in critical situations. Key Features of the Early Warning Smartwatch The...
Continue Reading